Accord Backed In EU For Trastuzumab And Apixaban

Part Of May Meeting of EMA’s CHMP

 
• By Dean Rudge
  
Green_Light
Accord's applications for biosimilar trastuzumab and generic apixaban have been greenlit • Source: Shutterstock

More from Biosimilars

More from Products